Studium tyrosin kinasového inhibitoru vandetanibu vázaného v apoferritinu a lipozomech

Autor: Jáklová, Kateřina

5 Abstract In this thesis the anticancer drug vandetanib was studied. Vandetanib is a tyrosine kinase inhibitor affecting signalling of vascular endothelial growth factor receptor (VEGFR), epidermal growth factor receptor (EGFR) or RET protooncogene

Externí odkaz: http://www.nusl.cz/ntk/nusl-434877

Cytochrome P450 and flavin-containing monooxygenase enzymes are responsible for differential oxidation of the anti-thyroid-cancer drug vandetanib by human and rat hepatic microsomal systems

Autor: Indra, Radek, Pompach, Petr, Vavrová, Katarína, Jáklová, Kateřina, Heger, Zbyněk, Adam, Vojtěch, Eckschlager, Tomáš, Kopečková, Kateřina, Arlt, Volker Manfred, Stiborová, Marie ^*

Publikováno v: In Environmental Toxicology and Pharmacology February 2020 74

Transcriptomic Signatures of Antibody-mediated Rejection in Early Biopsies With Negative Histology in HLA-incompatible Kidney Transplantation

Autor: Hruba, Petra, Klema, Jiri, Mrazova, Petra, Girmanova, Eva, Jaklova, Katerina, Voska, Ludek, Kment, Martin, Mackova, Martina, Osickova, Klara, Hanzal, Vladimir, Halloran, Philip F., Viklicky, Ondrej

Publikováno v: Transplantation; January 2025, Vol. 11 Issue: 1 pe1741-e1741, 1p

Transcriptomic Signatures of Antibody-mediated Rejection in Early Biopsies With Negative Histology in HLA-incompatible Kidney Transplantation.

Autor: Hruba P; Transplant Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czech Republic., Klema J; Department of Computer Science, Czech Technical University, Prague, Czech Republic., Mrazova P; Transplant Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czech Republic., Girmanova E; Transplant Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czech Republic., Jaklova K; Department of Immunogenetics, Institute for Clinical and Experimental Medicine, Prague, Czech Republic., Voska L; Department of Clinical and Transplant Pathology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic., Kment M; Department of Clinical and Transplant Pathology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic., Mackova M; Department of Medicine, University of Alberta, Edmonton, AB, Canada., Osickova K; Department of Nephrology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic., Hanzal V; Department of Nephrology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic., Halloran PF; Department of Medicine, University of Alberta, Edmonton, AB, Canada.; Alberta Transplant Applied Genomics Centre, Edmonton, AB, Canada., Viklicky O; Transplant Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.; Department of Nephrology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.

Publikováno v: Transplantation direct [Transplant Direct] 2024 Dec 13; Vol. 11 (1), pp. e1741. Date of Electronic Publication: 2024 Dec 13 (Print Publication: 2025).